After being rebuffed three times by Shire, AbbVie announced a sweetened bid of $51.5 billion for the Irish pharmaceutical company. Advising AbbVie are Herbert Smith Freehills and Sullivan & Cromwell; Shire turned to Slaughter & May and Davis Polk & Wardwell.
July 08, 2014 at 07:04 PM
1 minute read
Update, 7/18/14, 10 a.m. EST: This story has been updated to include the names of Sullivan & Cromwell’s deal team.
After being rebuffed three times by Shire PLC, AbbVie Inc. announced Tuesday that it was sweetening its bid to buy the Irish pharmaceutical company in a renewed attempt to reincorporate in the U.K.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Duane Morris LLP seeks a full-time staff litigation attorney who has practiced between 3-5 years. Experience will include drafting motions, ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
The American Lawyer provides the most informed and trusted source of news, data, analysis and forecasting on the global business of law.
